Efficacy of Contraceptive Methods chart – new edition 2019

Family Planning Alliance Australia, 2019

How effective is each contraceptive method? This revised chart compares methods of contraception for their efficacy. 

The figures have been derived by expert consensus using results from a variety of studies, selecting figures from studies which appear to be most comparable to Australian conditions.

Clinical Education Forum Recording: Contraception Update

SHINE SA, November 2018

Clinicians:  SHINE SA is pleased to present the following Clinical Forum by Dr Amy Moten on the topic of Contraception.

This recording is available free of charge, and access is limited to three months only.

This forum covers emergency contraception and new formulations of the Pill.

3 Category 2 RACGP Points can be awarded on completion of the forum.

Recording length: 1 hour 18 minutes

Rise of contraceptive apps sparks fears over unwanted pregnancies

Guardian, 

Clinical Education Forums at SHINE SA

SHINE SA, April 2018

SHINE SA hosts regular education sessions focused on clinically relevant issues. These sessions are available for doctors, nurses, midwives and other interested professionals. QI&CPD points can be applied for each session.

Forums include light refreshments, an educational presentation (1.5 hours CPD) and networking opportunities.

SHINE SA is trialling various software and all forums will be recorded and, quality permitting, uploaded for later access.  Presenters will be recorded for video and audio, but audience will be audio recorded only.

UPCOMING CLINICAL FORUMS:

Tuesday 12 June
Topic: Cervical Screening Update
Presenter: Dr Amy Moten
Attendance at this forum will ensure your knowledge of the National Cervical Screening Renewed Guidelines is accurate and in line with best practice principles.  SA Cervix Screening Program will have updated resources available on the day for you to add to your toolbox.

Tuesday 24 July
Topic: Syphilis
Presenter: Dr Danae Kent
This forum will cover recent trends in syphilis infection, syphilis serology and current recommendations for treatment.  Come along and have your questions on this complex infection answered.

Tuesday 18 September
Topic: Update on Sexually Transmitted infections
Presenter: Dr Danae Kent
This forum will cover current trends in sexually transmitted infections and include recent updates to the Australian STI Management Guidelines for Use in Primary Care.

Tuesday 27 November
Topic: Contraception Update
Presenter: Dr Amy Moten
Network with peers before the silly season is upon us while hearing the latest trends and recommendations in contraception.

FORUM DETAILS:

Where: SHINE SA, 64c Woodville Road, Woodville

Time: 6pm registration with presentations 6.30 – 8.30pm

Fee: No cost to attend

DOWNLOAD FLYER:

Clinical Education Forums flyer

Access to recorded forums:  If you are interested in accessing recorded forums, please email shinesacourses@shinesa.org.au with the following information:
1. Forum Topic
2. Your full name
3. Your occupation (doctor, nurse, midwife, other – please state)
4. Your preferred email address

Withdrawing Depo-Provera contraceptives would result in more lives lost than HIV infections prevented

aidsmap / nam,  11 January 2018

Even if Depo-Provera and other contraceptive injections raise the risk of HIV infection, withdrawing them from use in African countries would greatly increase maternal mortality, a modelling study has shown. The loss of life due to pregnancy complications and unsafe abortions would far outweigh the number of HIV infections prevented, according to the study published in the December issue of Global Health: Science and Practice.

SHINE SA Media Release: Response to the call to ban Diane-35

SHINE SA, issued 13th December 2017

SHINE SA believes everyone should have access to contraceptive choices, and that decisions about contraception are best made in conjunction with a healthcare professional.

Cyproterone acetate pills, commonly known as Diane-35 appear to be associated with a higher risk of deep venous thrombosis (DVT) than levonorgestrel (LNG) containing pills, although the overall risk is still very low for most people.

For those who choose combined pills, we recommend as first choice the pills with lowest risk: those containing levonorgestrel or norethisterone as their progesterone. However, the other progestogen choices, which all carry a small increased risk of DVT compared to LNG, may be utilised if specific added benefits are required. Health professionals can review over time the experience individuals may have with their contraceptive choice.

Cyproterone acetate can be used as treatment for signs of androgenisation in people such as severe acne (involving inflammation or nodularity, or risk of scarring) where prolonged oral antibiotics or local treatment alone have not been successful, or idiopathic hirsutism of mild to moderate degree. The oral contraceptive pill containing cyproterone acetate can also provide effective oral contraception in this patient group.
People who have concerns should seek advice from their doctor before stopping their oral contraceptive pill.

Download Media release (PDF): Response to the call to ban Diane-35 SHINE SA Diane35_13 Dec 17_FS